These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 2306672

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Comparative activity of three new fluoroquinolones.
    Coll R, Esteve M, Moros M, Parés J, Xicota MA.
    Chemioterapia; 1987 Jun; 6(2 Suppl):152-3. PubMed ID: 3509374
    [No Abstract] [Full Text] [Related]

  • 6. In vitro activity of E-3846, a new fluoroquinolone, against gram-negative and gram-positive bacteria.
    Moros M, Coll R, Esteve M, Parés J, Xicota MA.
    Chemioterapia; 1987 Jun; 6(2 Suppl):149-51. PubMed ID: 3509373
    [No Abstract] [Full Text] [Related]

  • 7. [In vitro fluoroquinolone resistance in ocular bacterial isolates].
    Sun XG, Wang ZQ, Li R, Chen L, Jin XY, Luo SY.
    Zhonghua Yan Ke Za Zhi; 2003 Mar; 39(3):163-6. PubMed ID: 12880574
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. An ophthalmologist's guide to understanding antibiotic susceptibility and minimum inhibitory concentration data.
    Kowalski RP, Yates KA, Romanowski EG, Karenchak LM, Mah FS, Gordon YJ.
    Ophthalmology; 2005 Nov; 112(11):1987. PubMed ID: 16183128
    [Abstract] [Full Text] [Related]

  • 10. [In vitro determination of the sensitivity of mycobacteria to fluoroquinolones].
    Dailloux M, Petitpain N, Henry C, Weber M.
    Pathol Biol (Paris); 1989 May; 37(5):346-9. PubMed ID: 2780092
    [Abstract] [Full Text] [Related]

  • 11. Correlation of in vitro activities of the fluoroquinolones to their in vivo efficacies.
    Fernandes PB, Swanson RN.
    Drugs Exp Clin Res; 1988 May; 14(6):375-8. PubMed ID: 3145851
    [Abstract] [Full Text] [Related]

  • 12. In vitro antimicrobial activity of sulfonamides against some porcine pathogens.
    Mengelers MJ, van Klingeren B, van Miert AS.
    Am J Vet Res; 1989 Jul; 50(7):1022-8. PubMed ID: 2774319
    [Abstract] [Full Text] [Related]

  • 13. A multicenter study on the comparative in vitro activity of fleroxacin and three other quinolones: an interim report from 27 centers.
    Beskid G, Prosser BL.
    Am J Med; 1993 Mar 22; 94(3A):2S-8S. PubMed ID: 8383919
    [Abstract] [Full Text] [Related]

  • 14. In vitro susceptibility of porcine respiratory pathogens to tilmicosin.
    DeRosa DC, Veenhuizen MF, Bade DJ, Shryock TR.
    J Vet Diagn Invest; 2000 Nov 22; 12(6):541-6. PubMed ID: 11108454
    [Abstract] [Full Text] [Related]

  • 15. Susceptibility pattern of bacterial isolates to lomefloxacin.
    Lalitha MK, Nisha AK, Bhattacharya SS, Ramamoorthy U, Lal HM.
    Indian J Med Res; 1990 May 22; 91():182-4. PubMed ID: 2397938
    [Abstract] [Full Text] [Related]

  • 16. In vitro susceptibility of avian mycoplasmas to enrofloxacin, sarafloxacin, tylosin, and oxytetracycline.
    Wang C, Ewing M, Aarabi SY.
    Avian Dis; 2001 May 22; 45(2):456-60. PubMed ID: 11417828
    [Abstract] [Full Text] [Related]

  • 17. In vitro susceptibility of some porcine respiratory tract pathogens to aditoprim, trimethoprim, sulfadimethoxine, sulfamethoxazole, and combinations of these agents.
    Mengelers MJ, van Klingeren B, van Miert AS.
    Am J Vet Res; 1990 Nov 22; 51(11):1860-4. PubMed ID: 2240813
    [Abstract] [Full Text] [Related]

  • 18. In vitro activity of the aryl-fluoroquinolones A-56619 and A-56620 and evaluation of disk susceptibility tests.
    Barry AL, Jones RN, Thornsberry C, Ayers LW, Gavan TL, Gerlach EH.
    Eur J Clin Microbiol; 1986 Feb 22; 5(1):18-22. PubMed ID: 2938944
    [Abstract] [Full Text] [Related]

  • 19. In vitro activity of sparfloxacin (AT-4140 and CI-978), a new quinolone antimicrobial agent, against Haemophilus and gram-positive cocci.
    Rudrik JT, Ferrigno SR, Gee SL.
    Diagn Microbiol Infect Dis; 1991 Feb 22; 14(4):355-60. PubMed ID: 1889186
    [Abstract] [Full Text] [Related]

  • 20. In vitro activity of fleroxacin against aerobic gram-positive bacteria including Corynebacterium jeikeium.
    Hohl P, Felber AM.
    Chemotherapy; 1990 Feb 22; 36(6):403-6. PubMed ID: 2127242
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.